3NDT

HIV-1 Protease Saquinavir:Ritonavir 1:1 complex structure

Summary for 3NDT

Entry DOI	10.2210/pdb3ndt/pdb
Related PRD ID	PRD_000454
Descriptor	Protease, (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1 -phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide, CHLORIDE ION, ... (6 entities in total)
Functional Keywords	hydrolase, aids, aspartyl protease, carbamylation, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological source	Human immunodeficiency virus type 1 BH10 (HIV-1)
Cellular location	Matrix protein p17: Virion (Potential). Capsid protein p24: Virion (Potential). Nucleocapsid protein p7: Virion (Potential). Reverse transcriptase/ribonuclease H: Virion (Potential). Integrase: Virion (Potential): P03366
Total number of polymer chains	4
Total formula weight	45019.17
Authors	Geremia, S.,Olajuyigbe, F.M.,Demitri, N. (deposition date: 2010-06-08, release date: 2011-07-20, Last modification date: 2023-09-06)
Primary citation	Olajuyigbe, F.M.,Demitri, N.,Geremia, S. Investigation of 2-Fold Disorder of Inhibitors and Relative Potency by Crystallizations of HIV-1 Protease in Ritonavir and Saquinavir Mixtures Cryst.Growth Des., 11:4378-4385, 2011 Cited by DOI: 10.1021/cg200514z PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.72 Å)

Structure validation